Showing results (191-200 of 266) with videos related to
Sort By:
Pageof 27
Journal of Immunology (Baltimore, Md. : 1950)|April 19, 2003
A fractal clonotype distribution in the CD8+ memory T cell repertoire could optimize potential for immune responsesYuri N Naumov, Elena N Naumova, Kevin T Hogan, et al.Scandinavian Journal of Rheumatology|January 12, 2021
Social stressors and risk of rheumatoid arthritis and their relationship to known modifiable risk factors: results from the Swedish EIRA studyL Hedenstierna, C H Opava, J Askling, et al.Journal of Virology|November 3, 2006
Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicryMarkus Cornberg, Brian S Sheridan, Frances M Saccoccio, et al.The American Journal of Pathology|March 30, 2010
Pathological features of heterologous immunity are regulated by the private specificities of the immune repertoireSiwei Nie, Sue-Jane Lin, Sung-kwon Kim, et al.The American Journal of Pathology|September 26, 2003
Specific history of heterologous virus infections determines anti-viral immunity and immunopathology in the lungHong D Chen, Armando E Fraire, Isabelle Joris, et al.Veterinary Clinical Pathology|June 14, 2023
Biological variation of biochemical urine and serum analytes in healthy dogsAnna K Selin, Inger Lilliehöök, Johannes Forkman, et al.Nature Structural & Molecular Biology|March 3, 2017
Broad TCR repertoire and diverse structural solutions for recognition of an immunodominant CD8+ T cell epitopeInYoung Song, Anna Gil, Rabinarayan Mishra, et al.Scandinavian Journal of Rheumatology|February 25, 2021
Widespread non-joint pain in early rheumatoid arthritisMec Schelin, H Westerlind, J Lindqvist, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2015
Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosisT Frisell, L Forsberg, N Nordin, et al.European Journal of Neurology|February 1, 2012
Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15M Bäärnhielm, A K Hedström, I Kockum, et al.Pageof 27